fluorodeoxyglucose f18 has been researched along with Cerebral Malaria in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Endo, K; Higuchi, T; Ikeda, E; Inoue, T; Katakura, K; Kawai, S; Khan, N; Sugiyama, M; Suzuki, M; Tomiyoshi, K; Yamaguchi, H; Zhang, H | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and Cerebral Malaria
Article | Year |
---|---|
Cerebral metabolic reduction in severe malaria: fluorodeoxyglucose-positron emission tomography imaging in a primate model of severe human malaria with cerebral involvement.
Topics: Animals; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Macaca; Malaria, Cerebral; Male; Plasmodium; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index | 2004 |